• We are a fully integrated vaccine company with two travel vaccines on the market.

  • Dedicated to innovation in vaccine research and development.

  • Valneva’s R&D focuses on vaccines addressing high unmet medical needs.

  • Valneva covers the full value chain from research to market.

Welcome to Valneva
A fully integrated, commercial stage biotech company focused on developing innovative lifesaving vaccines.


Download 2017 Valneva Annual Business Report

August 2, 2018  

Valneva Delivers Strong IXIARO® Sales Growth and Reports Further Progress on Key R&D Programs in H1

Read more    

— Stock information


— July 2, 2018
Valneva Announces Significant Progress of its Lyme Disease Vaccine Candidate

Read more 
— Financial Calendar

November 8, 2018
Q3 Results 2018

See all dates


News in German


Images, presentations and videos


learn more
play video Company Video

– Upcoming conferences

October 8-9
European Large & Midcap Event, Paris

October 11-13
Biotech made in Vienna: "From Landsteiner to global products for infectious disease control"
6th Semmering symposium, Vienna

October 29-31
World Vaccine Congress Europe, Lisbon

November 13-14
Stifel 2018 Healthcare Conference, New York
Please update your browser...